Total Payments
$326,711
2024 Payments
$22,785
Companies
33
Transactions
1,028
Medicare Patients
8,319
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$198,079 (60.6%)
Consulting$40,663 (12.4%)
Food & Beverage$34,148 (10.5%)
Travel$32,633 (10.0%)
Research$21,105 (6.5%)
Education$82.05 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $169,328 | 76 | 51.8% |
| Consulting Fee | $40,663 | 36 | 12.4% |
| Food and Beverage | $34,148 | 778 | 10.5% |
| Travel and Lodging | $32,633 | 120 | 10.0% |
| Unspecified | $21,105 | 3 | 6.5% |
| Honoraria | $16,750 | 5 | 5.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,500 | 4 | 2.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,000 | 1 | 0.9% |
| Long term medical supply or device loan | $501.40 | 1 | 0.2% |
| Education | $82.05 | 4 | 0.0% |
Payments by Type
General
$305,605
1,025 transactions
Research
$21,105
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $119,513 | 362 | $0 (2022) |
| ABBVIE INC. | $65,161 | 128 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $57,893 | 100 | $0 (2021) |
| Alcon Vision LLC | $20,422 | 103 | $0 (2024) |
| Sight Sciences, Inc. | $18,377 | 43 | $0 (2024) |
| EllexiScience | $11,464 | 2 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $11,140 | 36 | $0 (2021) |
| Glaukos Corporation | $9,443 | 52 | $0 (2024) |
| Nova Eye, Inc. | $3,099 | 3 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $2,590 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,785 | 83 | ABBVIE INC. ($16,983) |
| 2023 | $47,211 | 158 | AbbVie Inc. ($28,178) |
| 2022 | $42,625 | 132 | ABBVIE INC. ($19,967) |
| 2021 | $43,049 | 147 | Allergan, Inc. ($24,134) |
| 2020 | $38,887 | 68 | Allergan, Inc. ($28,346) |
| 2019 | $61,560 | 206 | Allergan Inc. ($27,406) |
| 2018 | $54,410 | 161 | Allergan Inc. ($27,336) |
| 2017 | $16,185 | 73 | EllexiScience ($11,464) |
All Payment Transactions
1,028 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| 12/09/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: EYE CARE | ||||||
| 12/03/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: EYE CARE | ||||||
| 11/16/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: EYE CARE | ||||||
| 11/15/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $44.80 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/07/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Ophthalmology | ||||||
| 11/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: EYE CARE | ||||||
| 11/01/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: EYE CARE | ||||||
| 10/01/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/25/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $186.21 | General |
| Category: Glaucoma | ||||||
| 09/18/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: EYE CARE | ||||||
| 08/26/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: OPTOMETRY | ||||||
| 08/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Ophthalmology | ||||||
| 08/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: EYE CARE | ||||||
| 08/06/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $73.02 | General |
| Category: Ophthalmology | ||||||
| 08/02/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Ophthalmology | ||||||
| 07/17/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $104.57 | General |
| Category: Dry eyes | ||||||
| 07/16/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Dry eyes | ||||||
| 07/09/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: EYE CARE | ||||||
| 06/26/2024 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $149.97 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Outcomes of Ab-Externo XEN 45 Placement ? A New Delivery ? in Patients With Glaucoma: EXPAND Study | Allergan, Inc. | $21,100 | 2 |
| XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma Gold-Standard Pathway Study GPS | Allergan Inc. | $5.43 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,743 | 2,428 | $549,547 | $253,962 |
| 2022 | 21 | 1,927 | 2,549 | $484,765 | $226,088 |
| 2021 | 20 | 2,157 | 2,722 | $642,507 | $310,613 |
| 2020 | 22 | 2,492 | 2,964 | $557,512 | $234,417 |
Total Patients
8,319
Total Services
10,663
Medicare Billing
$1.0M
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 422 | 874 | $117,990 | $71,035 | 60.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 48 | 67 | $84,822 | $32,845 | 38.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 288 | 370 | $60,310 | $21,485 | 35.6% |
| 66183 | Insertion of eye fluid drainage device | Facility | 2023 | 17 | 20 | $36,000 | $19,564 | 54.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 159 | 174 | $32,712 | $18,624 | 56.9% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 17 | 18 | $30,222 | $12,262 | 40.6% |
| 66250 | Revision or repair of operative wound of eye | Office | 2023 | 12 | 19 | $23,313 | $10,645 | 45.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 78 | 78 | $19,344 | $10,467 | 54.1% |
| 66250 | Revision or repair of operative wound of eye | Facility | 2023 | 14 | 19 | $23,313 | $8,406 | 36.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 228 | 253 | $18,975 | $8,305 | 43.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 22 | 22 | $13,800 | $7,123 | 51.6% |
| 65855 | Laser repair to improve eye fluid flow | Facility | 2023 | 28 | 39 | $25,350 | $7,117 | 28.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 80 | 113 | $9,506 | $5,703 | 60.0% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 21 | 22 | $14,300 | $5,011 | 35.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 19 | 20 | $6,000 | $3,123 | 52.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 11 | 11 | $6,600 | $3,063 | 46.4% |
| 92250 | Photography of the retina | Office | 2023 | 88 | 90 | $14,220 | $3,017 | 21.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 83 | 88 | $4,488 | $2,253 | 50.2% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 17 | 17 | $2,125 | $1,298 | 61.1% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2023 | 32 | 45 | $2,250 | $1,273 | 56.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 25 | 35 | $1,867 | $1,000 | 53.6% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 34 | 34 | $2,040 | $344.24 | 16.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 443 | 860 | $113,718 | $67,431 | 59.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 44 | 60 | $75,960 | $27,934 | 36.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 202 | 224 | $42,112 | $24,031 | 57.1% |
About Dr. H Tanaka, MD
Dr. H Tanaka, MD is a Ophthalmology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285723411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. H Tanaka, MD has received a total of $326,711 in payments from pharmaceutical and medical device companies, with $22,785 received in 2024. These payments were reported across 1,028 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($169,328).
As a Medicare-enrolled provider, Tanaka has provided services to 8,319 Medicare beneficiaries, totaling 10,663 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location San Francisco, CA
- Active Since 10/12/2006
- Last Updated 10/14/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1285723411
Products in Payments
- XEN (Device) $64,205
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $54,066
- DURYSTA (Drug) $48,874
- Rhopressa (Drug) $34,173
- rhopressa (Drug) $13,170
- OMNI(R) SURGICAL SYSTEM (US) (Device) $12,402
- VYZULTA (Drug) $11,054
- rocklatan (Drug) $10,466
- Rocklatan (Drug) $10,268
- Simbrinza (Drug) $8,117
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $6,687
- OMNI (Device) $5,741
- RESTASIS (Drug) $4,527
- Ahmed Glaucoma Valve (Device) $2,353
- LUMIGAN (Drug) $1,057
- TYRVAYA (Drug) $1,030
- HYDRUS Microstent (Device) $970.90
- iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device) $650.00
- ORA (Device) $504.10
- LUMERA (Device) $501.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in San Francisco
Dr. Daniel Schwartz, M.d, M.D
Ophthalmology — Payments: $8.0M
Ophthalmology $8.0M
Shan Lin, Md, MD
Ophthalmology — Payments: $437,860
Ophthalmology $437,860
Dr. Eugene De Juan, Md, MD
Ophthalmology — Payments: $349,911
Ophthalmology $349,911
Dr. Jay Stewart, Md, MD
Ophthalmology — Payments: $295,001
Ophthalmology $295,001
Dr. Scott So, M.d, M.D
Ophthalmology — Payments: $172,800
Ophthalmology $172,800
Dr. Gerami Seitzman, M.d, M.D
Ophthalmology — Payments: $77,123
Ophthalmology $77,123